Ljungman, Lisa http://orcid.org/0000-0003-1406-6329
Remes, Tiina
Westin, Elisabeth
Huittinen, Alina
Lönnqvist, Tuula
Sirkiä, Kirsti
Rantala, Heikki
Ojaniemi, Marja
Harila, Marika
Lähteenmäki, Päivi
Arikoski, Pekka
Wikman, Anna
Harila-Saari, Arja
Funding for this research was provided by:
Special State Grants for Health Research in the Department of Pediatric and Adolescence, Oulu University Hospital, Finland
Väre Foundation for Pediatric Cancer Research, Finland
The Foundation of Päivikki and Sakari Sohlberg
The Foundation of Arvo and Lea Ylppö, Finland
The Foundation for Pediatric Research, Finland
The Foundation of Emil Aaltonen, Finland
The Cancer Society of Finland
The Foundation of Thelma Mäkikyrö, Finland
The Cancer Foundation of Northern Finland
The Aamu Finnish Childhood Cancer Foundation
Stiftelsen Alma och K. A. Snellman Säätiö
The Foundation of Märta Donner, Finland
Barncancerfonden (TJ2019-0045)
Uppsala University
Article History
Received: 4 October 2021
Accepted: 9 February 2022
First Online: 3 March 2022
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the institutional review boards of the Oulu, Kuopio, Turku, Tampere, and Helsinki university hospitals, Finland (reference numbers 73/2010 and 159/2010).
: Informed consent was obtained from all individual participants included in the study.
: Patients signed informed consent regarding publishing their data.
: T.R. has received financial support for attending symposia from the Cancer Foundation of Northern Finland; Foundation of Arvo and Lea Ylppö, Finland; the Foundation for Pediatric Research, Finland; and PtcBio, Orion Pharma, and Biogenes; P.A. has received financial support for attending symposia from AbbVie and Alexion; P.L. has received financial support for attending symposia from Shire, Sobi, Bayer, and the Cancer Foundation of Finland; T.L. has received a speaker honorarium from Actelion Pharmaceuticals and Biomarin; The other authors report no conflict of interest.